Do We Really Need Omicron Spike-Based Updated COVID-19 Vaccines? Evidence and Pipeline

The wild-type SARS-CoV-2 Spike-based vaccines authorized so far have reduced COVID-19 severity, but periodic boosts are required to counteract the decline in immunity. An accelerated rate of immune escape to vaccine-elicited immunity has been associated with Spike protein antigenic shifts, as seen i...

Descripción completa

Detalles Bibliográficos
Autores principales: Focosi, Daniele, Maggi, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692555/
https://www.ncbi.nlm.nih.gov/pubmed/36366586
http://dx.doi.org/10.3390/v14112488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9692555/
https://www.ncbi.nlm.nih.gov/pubmed/36366586
http://dx.doi.org/10.3390/v14112488

Ejemplares similares